FC
SURF

FORA Capital’s Surface Oncology, Inc. Common Stock SURF Stock Holding History

FORA Capital’s Portfolio SURF Stock Details SURF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-2,925
Closed -$20K – 1183
2020
Q3 		$20K Sell
2,925
-14,905
-84% -$90.4K 0.01% 586
2020
Q2 		$117K Buy
+17,830
New +$64.4K 0.04% 452

Other funds holding SURF

AVAI
Atlas Venture Associates IX Boston, Massachusetts $11.8M AUM 58.35% 1-Year Est. Return
AVAX
Atlas Venture Associates XI Cambridge, Massachusetts $631M AUM
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return

FORA Capital's SURF Position: Q4 2020 in Review

FORA Capital sold out of Surface Oncology, Inc. Common Stock (SURF) in Q4 2020, closing a stake of 2,925 shares — an estimated $20K sold.

FORA Capital first reported a position in SURF in Q2 2020 and held it in 2 quarters. The position peaked at $117K in Q2 2020. 91 funds tracked by Wall St. Rank hold SURF as of Q4 2020.

  • FORA Capital reported no remaining Surface Oncology, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • FORA Capital sold 2,925 Surface Oncology, Inc. Common Stock shares in Q4 2020, an estimated $20K.
  • FORA Capital first reported a position in Surface Oncology, Inc. Common Stock in Q2 2020 and held it in 2 quarters.
  • FORA Capital's Surface Oncology, Inc. Common Stock position peaked at $117K in Q2 2020.
  • 91 funds tracked by Wall St. Rank held Surface Oncology, Inc. Common Stock as of Q4 2020.

Based on FORA Capital's 13F filing for Q4 2020, filed 12 Feb 2021.